iiinova — where your digital self keeps evolving

Reposted by Euromit-2026

Tisento Therapeutics @tisentotx.bsky.social · 04/06/2026

We had a wonderful few days at #Euromit2026 with many of the leading mitochondrial medicine researchers and clinicians around the world. Thanks for sharing your important work and learning about ours! #PRIZM #MELAS #MitochondrialDisease #Biosky @euromit-2026.bsky.social

031

Euromit-2026 @euromit-2026.bsky.social · 29/05/2026

Partner #Euromit2026 to #Angers, the #FondationVISIO is invested in scientific research projects, technological innovation, cultural, educational and sporting accessibility for visually impaired children and adults. A commitment that resonates with the spirit of the Euromit congress.

020

Euromit-2026 @euromit-2026.bsky.social · 18/05/2026

Stealth BioTherapeutics is proud to support #Euromit2026 as a Gold Sponsr Come meet us at exhibition booth #3 to learn about our latest research. #euromit2026 #MitochondiralMedicine

010

Euromit-2026 @euromit-2026.bsky.social · 18/05/2026

Connecting the thymidine kinase 2 deficiency (TK2d) community at #Euromit2026 The congress brings together experts in mitochondrial disease research. As a Diamond sponsor, UCB will contribute to scientific exchange through sessions, a symposium and exhibition presence. 🤝 #TK2d #MitochondrialDisease

000

Euromit-2026 @euromit-2026.bsky.social · 12/05/2026

#OMEICOS is pleased to participate in #EUROMIT-2026 this May as Silver Sponsor. We firmly believe shared insights drive innovation 🚀 and we are excited to connecting with the community. www.omeicos.com #MitochondrialDisease #MitochondrialHealth #Mitochondria #PMD

110

Euromit-2026 @euromit-2026.bsky.social · 06/05/2026

From thymidine kinase 2 deficiency (TK2d) recognition to management Diagnosis pathways are rarely linear and shaped by key clinical decisions. At #Euromit2026, UCB joins scientific exchange on TK2d, through sessions, exhibition, and a symposium on the journey from recognition to disease management.💬

011

Euromit-2026 @euromit-2026.bsky.social · 05/05/2026

Stealth BioTherapeutics is proud to support #Euromit2026 as a Gold Sponsor. Come meet us at exhibition booth #3 to learn about our latest research. #euromit2026 #MitochondrialMedicine

000

Euromit-2026 @euromit-2026.bsky.social · 05/05/2026

Proud to welcome Fondation VISIO at the #Euromit2026 Congress. Spotlight on their call for early-career researchers in ophthalmology: innovative clinical projects, developed with French institutions, to advance care and improve outcomes in visual impairment. 🔬🤝

000

Euromit-2026 @euromit-2026.bsky.social · 04/05/2026

📢EUROMIT 2026 – Registration deadline extended The registration deadline has been extended. 🗓 New deadline: May 7, 2026 at 11:59 p.m. (Paris time) Registration remains open until this date.

010

Euromit-2026 @euromit-2026.bsky.social · 29/04/2026

⏳ The deadline is fast approaching! 📅 You have until May 1st, 2026 at 11:59 PM (Paris time) to register and be part of this exceptional edition. 🔔 Last chance to register! www.euromit2026.eu/registration/

euromit2026.eu

Registration

Register for Euromit 2026 congress : International Meeting on Mitochondrial Pathology in Angers, France (May 30–June 4). Early bird rates available until February 1, 2026.

011

Euromit-2026 @euromit-2026.bsky.social · 27/04/2026

Filnemus, the French rare neuromuscular diseases network, supports the Young investigators' day of EUROMIT 2026. The Filnemus network comprises 14 expert centers in mitochondrial diseases. To learn more about Filnemus: www.filnemus.fr #euromit2026 #RareDiseases

000

Euromit-2026 @euromit-2026.bsky.social · 22/04/2026

AMMi goes beyond advocacy, building connections, sharing knowledge, and strengthening the mito community in France. With IMP, we act globally to empower patients and support progress in research and care. #euromit2026 #AMMI #IMP #Mito #RareDiseases

010

Euromit-2026 @euromit-2026.bsky.social · 09/04/2026

𝐌𝐢𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫.𝐜𝐨𝐦, 𝐚 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐝𝐞𝐝𝐢𝐜𝐚𝐭𝐞𝐝 𝐭𝐨 𝐦𝐢𝐭𝐨𝐜𝐡𝐨𝐧𝐝𝐫𝐢𝐚𝐥 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬⁣ Launched by the French consortium MitoGether, it provides expert-validated and regularly updated information on mitochondrial diseases. A new essential resource for patients, physicians and Pharma. ⁣ mitogether.com

032

Euromit-2026 @euromit-2026.bsky.social · 31/03/2026

Committed since 1998, #AMMi has been a founding member of IMP since 2011. At @euromit-2026.bsky.social , we are joining forces for the 6,500 patients in France. Turning research into treatments: this has been our fight for nearly 30 years ! #euromit2026 #AMMI #IMP #Mito #RareDiseases

000

Euromit-2026 @euromit-2026.bsky.social · 27/03/2026

Discover LiCellMo™—the Live Cell Metabolic Analyzer delivering long‑term, precise insights into cellular energy metabolism. Follow metabolism as it happens. PHC Europe B.V. is a Silver Sponsor—visit us at our stand. #Euromit #PHCbi #LiCellMo

000

Euromit-2026 @euromit-2026.bsky.social · 26/03/2026

000

Euromit-2026 @euromit-2026.bsky.social · 23/03/2026

@tisentotx.bsky.social is proud to support #euromit2026 as a Silver Sponsor! Our clinical program in the rare #MitochondrialDisease #MELAS is evaluating zagociguat’s effect on symptoms that matter most to patients—including fatigue and cognitive dysfunction. Visit our booth at #Euromit2026#WeHearYou

021

Euromit-2026 @euromit-2026.bsky.social · 13/03/2026

Spotlight on clinical ophthalmology research at VISIO Foundation, attending #Euromit2026 in Angers. Patient-centered projects cover, for example, glaucoma, AMD, and rare eye diseases. Researchers can discover innovations and connect with a key player in clinical research.

002

Euromit-2026 @euromit-2026.bsky.social · 09/03/2026

NADMED is excited to join Euromit2026 as a Silver Sponsor, advancing dialogue in mitochondrial science and clinical translation. We bridge research and patient care through NAD and glutathione measurement, enabling insights from cells to tissue to whole blood. Connect with us to share insights!

Promotional banner for Euromit 2026 showing Henna Uusitalo and Liliya Euro
from NADMED, with event date and place and text about discussing mitochondrial science and NAD
measurement.

000

Euromit-2026 @euromit-2026.bsky.social · 20/02/2026

The VISIO Foundation at #Euromit2026: advancing visual health research For years, the VISIO Foundation has supported clinical research in neuro-ophthalmology. At @Euromit 2026, it highlights links between mitochondrial diseases and severe visual impairment. Follow them on LinkedIn or Instagram

000

Euromit-2026 @euromit-2026.bsky.social · 18/02/2026

Early Bird extended to Feb 27, 2026! Final chance to get the preferential rate. 🔗Register now: www.euromit2026.eu/registration/ EUROMIT 2026 – May 31–June 4, Angers - France #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

000

Euromit-2026 @euromit-2026.bsky.social · 16/02/2026

UCB is a Diamond Partner at #Euromit2026 💎 We look forward to discussing the latest advancements in thymidine kinase 2 deficiency (TK2d) with the mitochondrial community and sharing our commitment to optimize TK2d management. Meet us at Euromit2026! 🤝 #mitochondrialdisease #TK2d #raredisease #UCB

010

Euromit-2026 @euromit-2026.bsky.social · 13/02/2026

Only a few days left to get the Early Bird rate! Early Bird registration for EUROMIT 2026 ends on 17 February 2026 👉 Registration : lnkd.in/ecsTM5Gr 👉 Submit your abstract : lnkd.in/ejCS3e4t #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

Promotional image announcing the upcoming deadline for the Early Bird rate for EUROMIT 2026. At the top, the text reads “Take advantage before February 17, 2026!”. In the center, two tilted green shapes display the words “Early Bird” and “Rate”. The background features green, mitochondria‑like patterns on a black backdrop. At the bottom, a green band contains the text “EUROMIT 2026

000

Euromit-2026 @euromit-2026.bsky.social · 27/01/2026

📢 New update on our website! 👉Don't forget : early‑bird rates are available until Februray, 17 !! 👉 : www.euromit2026.eu/article/book... #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

euromit2026.eu

Book Early and Maximize Your Benefits

000

Euromit-2026 @euromit-2026.bsky.social · 22/01/2026

Fier de soutenir @euromit-2026.bsky.social! L'AMMi & IMP se mobilisent pour la recherche sur les maladies mitochondriales. Rendez-vous à Angers pour construire ensemble le futur de la médecine. #euromit2026 #rarediseases #PatientCare

Image montrant un chercheur au microscope, deux hélices d’ADN et des mitochondries en 3D. Les logos AMMi, IMP et Euromit 2026 sont présents. L’image illustre le lien entre recherche scientifique et soutien aux patients atteints de maladies mitochondriales. On ne lâche rien

100

Euromit-2026 @euromit-2026.bsky.social · 09/01/2026

📢 Call for Sponsorship – Euromit 2026! Become a sponsor and link your brand to one of the most awaited events in mitochondrial disease research. 👉 www.euromit2026.eu/article/call... #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

euromit2026.eu

Call for Sponsorship

011

Euromit-2026 @euromit-2026.bsky.social · 05/01/2026

Lucid Scientific is proud to join #Euromit2026 as a Silver Sponsor, supporting the global mitochondrial research community. Our Resipher system enables real-time, long-term measurement of cellular oxygen consumption. lucidsci.com?t=euromit #LucidScientific #Resipher #MitochondrialResearch

lucidsci.com

Lucid Scientific

Lucid Scientific is the maker of Resipher - the world's first handheld cell culture monitor to measure real-time oxygen consumption from inside an incubator.

011

Euromit-2026 @euromit-2026.bsky.social · 22/12/2025

📢 New update on our website! The Call for Abstracts for Euromit 2026 is open. 👉 Call for Abstracts : www.euromit2026.eu/article/call... #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

euromit2026.eu

Call for Abstracts – Euromit2026

010

Euromit-2026 @euromit-2026.bsky.social · 19/12/2025

🎓 Professionnels de santé : participez à EUROMIT2026 en mobilisant votre budget formation continue ! ✅ Le congrès est porté par le CFPS du CHU d’Angers, certifié Qualiopi. 📅 31 mai–4 juin 2026 #EUROMIT2026 #MitochondrialDisease #mitochondria @chuangers.bsky.social @univangers.bsky.social

000

Euromit-2026 @euromit-2026.bsky.social · 16/12/2025

🙏 Thanks to #KJERFrance for supporting #EUROMIT2026. Founded in 2013, the association is dedicated to Autosomal Dominant Optic Atrophy (ADOA), the most common hereditary optic neuropathy. Learn more 👉 www.kjer-france.org #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria

030

Euromit-2026 @euromit-2026.bsky.social · 09/12/2025

Proud to welcome Pharming Group as Gold Sponsor at #EUROMIT! A global leader in rare disease innovation, Pharming advances therapies for hereditary angioedema, APDS & mitochondrial disorders, bringing life-changing treatments to unserved communities worldwide. #EUROMIT2026 #MitochondrialDisease

110

Euromit-2026 @euromit-2026.bsky.social · 05/12/2025

🆕 New update! Young Investigators Day will take place the day before EUROMIT 2026. Don’t miss this unique chance for young scientists to connect and present your work ! 👉 www.euromit2026.eu/article/youn... #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria

euromit2026.eu

Young Investigator's day

032

Euromit-2026 @euromit-2026.bsky.social · 01/12/2025

✅ Euromit is now fully compliant with MedTech Europe standards! 👉 Official decision: cvs.solutions.iqvia.com/event/detail... Become a sponsor today: www.euromit2026.eu/become-partn... #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

Screenshot showing Euromit2026 compliance status on the MedTech Europe Conference Vetting System. All criteria — Location, Venue, Scientific Programme, Hospitality and Registration Programme, and Communication Programme — are marked as “Compliant.” Overall status: Compliant.

021

Euromit-2026 @euromit-2026.bsky.social · 25/11/2025

📢 Stay informed about the latest news from #Euromit2026 community! Our first news update is now live on the EUROMIT2026 website. Regularly, more info will be published here : www.euromit2026.eu/news/ ➡ Subscribe to the newsletter so you don’t miss a thing!

euromit2026.eu

Together, let’s make this congress an unforgettable moment !

000

Euromit-2026 @euromit-2026.bsky.social · 21/11/2025

🎉 Only 190 days until EUROMIT 2026! The mitochondrial research community will gather to share discoveries and advance understanding of mitochondrial diseases. 📅 Save the date! #EUROMIT2026 #MitochondrialDisease #mtDNA #mitochondria @chuangers.bsky.social @univangers.bsky.social

Promotional banner for EUROMIT 2026. Text reads: “EUROMIT 2026 is coming in 190 days, are you ready?” Event dates: “May 31st to June 4th, 2026” and location: “Angers, France.” A stopwatch icon shows “190” next to the phrase “Days to go euromit.” At the bottom, contact details: website “https://www.euromit2026.eu” and email “secretariat@euromit2026.eu.” Design features blue, purple, and white colors with a textured background.

020

Reposted by Euromit-2026

Payam Gammage @mito-oncogene.bsky.social · 03/11/2025

Excited to share our latest work in collaboration with the @edreznik.bsky.social lab @mskcancercenter.bsky.social, where we describe functionally dominant mitochondrial DNA mutations in patient tumors. So, what is functional dominance in mitochondrial genetics, I hear you ask? rdcu.be/eN1jm

rdcu.be

Functionally dominant hotspot mutations of mitochondrial ribosomal RNA genes in cancer

Nature Genetics - Analysis of 14,106 tumor genomes highlights recurrent mutations in mitochondrial ribosomal RNA encoded within the mitochondrial genome. Mutations occur at hotspot positions and...

16823

Euromit-2026 @euromit-2026.bsky.social · 10/10/2025

Want to be part of #Euromit2026? Here's a step-by-step guide to getting all the information you need in one place. 📆 Follow the thread below to stay update with deadlines @ua-recherche.bsky.social @chuangers.bsky.social #MitochondrialDisease #mtDNA #mitochondria 👇

110

Euromit-2026 @euromit-2026.bsky.social · 02/10/2025

📢 Call for abstract is now open !!! We invite you to submit your abstract for consideration as an oral or poster presentation at #Euromit2026. 👉 Submission portal www.euromit2026.eu/abstract-sub... #MitochondrialDisease #mtDNA #mitochondria @ua-recherche.bsky.social @chuangers.bsky.social

We invite you to submit your abstract for consideration as an oral or poster presentation at Euromit 2026, the international congress on mitochondrial diseases. Abstract submission deadline March 15, 2026. Follow the link to website www.euromit2026.eu

021

Euromit-2026 @euromit-2026.bsky.social · 18/09/2025

🎉 You asked for it… and here it is! The Euromit 2026 website is officially live! Take advantage of the preferential rate today thanks to EARLY-BIRD Registration 👉 www.euromit2026.eu #MitochondrialDisease #mtDNA #mitochondria #euromit2026 @ua-recherche.bsky.social

142

Euromit-2026 @euromit-2026.bsky.social · 01/09/2025

🔔 Sponsorship call is now open! Do not miss this unique opportunity to showcase your services, or technologies at the congress exhibition area or during one of the industry-sponsored symposia (limited offer). 📥 Get the brochure here : bit.ly/euromitsponsor or email : secretariat@euromit2026.eu

bit.ly

100

Euromit-2026 @euromit-2026.bsky.social · 18/08/2025

📢 Need #Euromit2026 rates for your funding application before they're published on our website ? ➡️ Obtain fee information in advance to facilitate your administrative procedures at 📧 secretariat@euromit2026.eu #euromit2026 #MitochondrialDisease #mtDNA #mitochondria @ua-recherche.bsky.social

001

Euromit-2026 @euromit-2026.bsky.social · 11/08/2025

🎯 Quick correction for #EUROMIT2026! We study the powerhouse of the cell, but our email skills clearly need some work! If you've reached out and haven't heard back, here's the correct contact: ✅ secretariat@euromit2026.eu Thanks for your patience while we debugged our communication pathway!

000

Euromit-2026 @euromit-2026.bsky.social · 29/07/2025

🔔 Join us as a sponsor of EUROMIT 2026 – The international event on mitochondrial pathology. 📩 Sponsorship offer will be sent first by email at the end of August. 📣 Not listed yet as a potential sponsor? Let us know — we’d love to include you. 📬 Contact us: secretariat@euromit2026.org

Image of Call for sponsorship concerning Euromit 2026. Request the sponsorship offer by e-mail at : secretariat@euromit2026.org

100

Euromit-2026 @euromit-2026.bsky.social · 24/07/2025

After a short summer break, we're back for the final invited speaker presentation ! ✨ Today, we’re introducing Anu Suomalainen-Wartiovaara, Stephen Tait, David Thorburn, Aleksandra Trifunovic, Carlo Viscomi. 👇

100

Euromit-2026 @euromit-2026.bsky.social · 19/06/2025

🎙️ Focus Speakers – Florian Rosenberger 👀 Curious to know who will be speaking at #euromit2026 ? ✨ Today, we’re introducing @frosenberger.bsky.social @ki.se who will be taking the stage at the congress. #euromit2026 #MitochondrialDisease #mtDNA #mitochondria @ua-recherche.bsky.social

Picture of Florian Rosenberger featuring his photo and a short biography. Florian Rosenberger will be speaking at Euromit congress in 2026 in Angers, France on Wednesday, June 3rd during the session entitled Innovative technologies. Florian Rosenberger is an assistant professor at the Karolinska Institutet in Stockholm, Sweden. His research explores how mitochondria maintain cellular health, respond to metabolic stress, and contribute to disease, with a focus on mitochondrial disorders. Using cutting-edge single-cell and spatial proteomics, his lab analyzes mitochondrial protein networks in different cell types and tissues to understand cell-specific vulnerabilities to metabolic diseases.

131

Euromit-2026 @euromit-2026.bsky.social · 17/06/2025

📢 We’re #hiring a Tenure-Track Junior Professor (CPJ) 🎯 Are you a top scientist in mitochondrial pathophysiology? Join us at the University of Angers in Mitovasc Unit @cnrsbiologie.bsky.social @inserm.fr #MitochondrialDisease #mtDNA #mitochondria @ua-recherche.bsky.social 👇 Apply by July 11

univ-angers.fr

Campagne Chaire Professeur Junior 2025 - Université Angers

111

Euromit-2026 @euromit-2026.bsky.social · 13/06/2025

🎙️ Focus Speakers – Julien Prudent 👀 Curious to know who will be speaking at #euromit2026 ? ✨ Today, we’re introducing Julien Prudent who will be taking the stage at the congress. #euromit2026 #MitochondrialDisease #mtDNA #mitochondria #angers @ua-recherche.bsky.social @mrc-mbu.bsky.social

Picture of Julien Prudent featuring his photo and a short biography. Julien Prudent will be speaking at Euromit congress in 2026 in Angers, France on Tuesday, June 2nd during the session entitled Mitochondrial communications. Julien Prudent is a group leader at the MRC Mitochondrial biology unit in Cambridge, UK. Using advanced microscopy, proteomic and biochemical techniques, his group studies how mitochondrial dynamics, membrane remodeling, and interactions with other organelles influence cell fate, metabolism, inflammation, and diseases such as cancer.

131

Euromit-2026 @euromit-2026.bsky.social · 10/06/2025

🎙️ Focus Speakers – Alessandro Prigione 👀 Curious to know who will be speaking at #euromit2026 ? ✨ Today, we’re introducing A. Prigione @aleprigio.bsky.social who will be taking the stage at the congress. #euromit2026 #MitochondrialDisease #mtDNA #mitochondria #angers @ua-recherche.bsky.social

Picture of Alessandro Prigione featuring his photo and a short biography. Alessandro Prigione will be speaking at Euromit congress in 2026 in Angers, France on Wednesday, June 3rd during the session entitled Innovative technologies. Alessandro Prigione is a professor at the Heinrich Heine University in Düsseldorf, Germany. His group uses patient-derived iPSCs to generate cerebral cells and organoids to study how mitochondrial dysfunction leads to neurological disorders such as Leigh syndrome. He uses advanced stem cell technologies, genome editing, and high-throughput drug screenings to understand disease mechanisms and identify potential therapies.

072